高龄非痴呆人群 amyloid β 沉积与疑似非阿尔茨海默病理的12年认知下降模式
该纵向观察研究纳入175名高龄非痴呆参与者,平均随访12.2年,根据淀粉样蛋白β(Aβ)和神经退行性变(ND)生物标志物分为四组。结果显示Aβ+/ND+组在所有认知领域下降最陡;单纯Aβ沉积与记忆、语言和执行功能下降相关,而单纯海马萎缩仅与视觉记忆下降相关。
要点
- 高龄非痴呆人群中Aβ和/或海马萎缩普遍存在(>75%)。
- Aβ+/ND+组在所有认知测验中下降最陡。
- 单纯Aβ沉积与记忆、语言和执行功能下降相关,单纯海马萎缩仅与视觉记忆下降相关。
核心结论
- 在高龄非痴呆人群中,Aβ和/或海马萎缩普遍存在(>75%)。
- 单纯海马体积萎缩仅与记忆下降相关,而单纯Aβ沉积与记忆、语言和执行功能下降相关。
- 这些发现提示Aβ+/ND-和Aβ-/ND+组存在不同的潜在病理生理过程。
研究设计与样本
- 纵向观察研究,平均随访12.2(2.2)年(范围7.2-15.1年),于2000年8月24日至2016年1月14日在学术医学中心进行。
- 纳入197名完成Ginkgo Evaluation of Memory研究、无痴呆且能接受磁共振成像的成人,最终175名纳入分析;140名(80%)认知正常,35名(20%)轻度认知障碍。
- 根据2009年Pittsburgh Compound B保留和海马体积将生物标志物分为Aβ-/ND-、Aβ+/ND-、Aβ-/ND+和Aβ+/ND+四组。
主要发现
- 175名参与者中,71名女性,104名男性;成像时平均(SD)年龄86.0(2.9)岁(范围82-95岁)。
- 42名(24.0%)为Aβ-/ND-,32名(18.3%)为Aβ+/ND-,35名(20.0%)为Aβ-/ND+,66名(37.7%)为Aβ+/ND+。
- 与Aβ-/ND-组相比,Aβ+/ND-组在言语和视觉记忆(-0.3513;95% CI,-0.5269至-0.1756)、执行功能(0.0158;95% CI,0.0013-0.0303)和语言(-0.1934;95% CI,-0.3520至-0.0348)测验中下降更快。
- Aβ-/ND+组较Aβ-/ND-参照组显示更快的视觉记忆下降(-0.3007;95% CI,-0.4736至-0.1279)。
- Aβ+/ND+组在所有认知测量中下降最陡。
临床怎么用
- 在高龄非痴呆人群中,应关注Aβ和神经退行性变生物标志物状态,以识别不同认知下降模式的风险。
- 单纯Aβ沉积者需监测记忆、语言和执行功能,单纯海马萎缩者需关注记忆下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The prevalence of pathologic conditions of the brain associated with Alzheimer disease increases strongly with age. Little is known about the distribution and clinical significance of preclinical biomarker staging in the oldest old, when most individuals without dementia are likely to have positive biomarkers. OBJECTIVE: To compare the patterns of long-term cognitive decline in multiple domains by preclinical biomarker status in the oldest old without dementia. DESIGN, SETTING, AND PARTICIPANTS: A longitudinal observational study with a mean (SD) of 12.2 (2.2) years (range 7.2-15.1 years) of follow-up was conducted in an academic medical center from August 24, 2000, to January 14, 2016, including and extending observations from the Ginkgo Evaluation of Memory study. A total of 197 adults who had completed the Ginkgo Evaluation of Memory study, were free of dementia, and were able to undergo magnetic resonance imaging were eligible for a neuroimaging study in 2009. Of these patients, 175 were included in the present analyses; 140 (80%) were cognitively normal and 35 (20%) had mild cognitive impairment. MAIN OUTCOMES AND MEASURES: Biomarker groups included amyloid β negative (Aβ-)/neurodegeneration negative (ND-), amyloid β positive (Aβ+)/ND-, Aβ-/neurodegeneration positive (ND+), and Aβ+/ND+ based on Pittsburgh Compound B retention and hippocampal volume in 2009. Participants completed baseline neuropsychological testing from 2000 to 2002 and annual testing from 2004 to 2016. Domains included memory, executive function, language, visual-spatial reasoning, and attention and psychomotor speed. Slopes of decline were evaluated with linear mixed models adjusted for age, sex, and years of education. RESULTS: Of the 175 participants (71 women and 104 men), at imaging, mean (SD) age was 86.0 (2.9) years (range, 82-95 years). A total of 42 participants (24.0%) were Aβ-/ND-, 32 (18.3%) were Aβ+/ND-, 35 (20.0%) were Aβ-/ND+, and 66 (37.7%) were Aβ+/ND+. On all cognitive measures, the Aβ+/ND+ group showed the steepest decline. Compared with the Aβ-/ND- group, the amyloid deposition alone (Aβ+/ND-) group showed faster decline on tests of verbal and visual memory (-0.3513; 95% CI, -0.5269 to -0.1756), executive function (0.0158; 95% CI, 0.0013-0.0303), and language (-0.1934; 95% CI, -0.3520 to -0.0348). The Aβ-/ND+ group showed faster visual memory decline than the Aβ-/ND- reference group (-0.3007; 95% CI, -0.4736 to -0.1279). CONCLUSIONS AND RELEVANCE: In the oldest old without dementia, presence of either or both Aβ and hippocampal atrophy is typical (>75%). Isolated hippocampal volume atrophy is associated only with greater decline in memory. However, isolated Aβ is associated with decline in memory plus language and executive functions. These findings suggest different underlying pathophysiologic processes in the Aβ+/ND- and Aβ-/ND+ groups.
引用
- Zhao Y, Tudorascu DL, Lopez OL, et al. Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia. JAMA Neurol. 2018. PMID: 29114732. doi:10.1001/jamaneurol.2017.3029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。